Global Nuclear Medicine Market By Type (Diagnosis (Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)) Treatment, Radioactive Iodine Therapy, Brachytherapy, Chemotherapy, Hormone Therapy, Proton Therapy, Alpha Emitters, Stereotactic Body Radiotherapy, Others) By Application (Thyroid disease, Gall bladder disease, Heart conditions, Cancer, Alzheimer’s disease, Endocrine Tumors, Neurology Disorders, Lymphoma, Others) By End Users (Hospitals and Clinics, Diagnostic Centers, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030